Summary
Marijuana components, such as Δ-9-tetrahydrocannabinol, and endogenous cannabinoids, such as anandamide and 2-arachydonoylglycerol, alter diverse immune functions. Two cannabinoid receptors have been discovered to date, the central cannabinoid receptor (CB1R) and the peripheral cannabinoid receptor (CB2R). The CB1R is expressed predominantly in the central nervous system. The CB2R is expressed mainly in cells of the immune system, suggesting that the CB2R is involved in immunoregulatory events. Cannabinoids have been shown to modulate diverse immune functions including cytokine production, lymphocyte proliferation, and humoral and cell-mediated immune responses. In addition, cannabinoids have been shown to induce different signal transduction pathways. However, the role of cannabinoids and their receptors in the immune system remains unclear. The objective of the experimental methods described herein is to investigate the role of CB2R activation in specific splenocyte and macrophage functions using a mouse lacking the CB2R. Interestingly, our findings, thus far suggest that basal CB2R activation modulates lymphocyte proliferation and cytokine secretion and macrophage phagocytic activity. Therefore, data obtained using the methodology described in this chapter will help us elucidate the role of cannabinoids and the CB2R in the immune system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Berdyshev, E. V., et al. (1997) Influence of fatty acid ethanolamides and delta-9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eur. J. Pharmacol, 330, 231–240.
Klein, T. W., Friedman, H., and Specter, S. (1998) Marijuana, immunity and infection. J. Neuroimmunol. 83, 102–115.
Klein, T. W., Newton, C., and. Friedman, H. (1998) Cannabinoid receptors and immunity. Immunol. Today 19(8), 373–381.
Srivastava, M. D., Srivastava, B. I. S., and Brouhard, B. (1998) Delta-9-tetrahydrocannabinol and cannabindiol alter cytokine production by human immune cells. Immunopharmacology. 40, 179–185.
Berdyshev, E. V.(2000) Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids 108, 169–190.
Gonsiorek, W., et al.(2000) Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol. Pharmacol. 57, 1045–1050.
Gardner, B., et al. (2002) Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-b. Biochem. Biophys. Res. Commun. 290, 91–96.
Parolaro, D., et al. (2002) Endocannabinoids in the immune system and cancer. Prostaglandins, Leukotrienes Essential Fatty Acids 66(2&3), 319–332.
Yuan, M., et al. (2002) Delta-9-tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J Neuroimmunol,. 133(1–2), 124–131.
Ihenetu, K., et al. (2003) Pharmacological characterisation of cannabinoid receptors inhibitng interleukin 2 release from human peripheral blood mononuclear cells. Eur. J. Pharmacol. 464, 207–215.
Klein, T., et al. (2004) Cannabinoid receptors and T helper cells. J. Neuroimmunol., 147,. 91–94.
Lopez-Rodriguez, M L., et al. (2005) Involvement of cannabinoids in cellular proliferation. Mini Rev. Med. Chem. 5(1), 97–106.
Rodriguez de Fonseca, F., et al.(2005) The endocannabinoid system: physiology and pharmacology. Alcohol, 40(1), 2–14.
Matsuda, L., et al. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346, 561–564.
Munro, S., Thomas, K. L., and Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365 61–65.
Felder, C. C. and. Glass, M. (1998) Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol,. 38, 179–200.
Herkenham, M., Lynn A. B., Johnson, M. R., Melvin, L. S., de Costa, B. R., Rice, K. C. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci.. 11(2), 563–583.
Glass, M., Dragunow, M. and. Faull, R. L. M. (1997) Cannabinoid receptors in the human brain—a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77(2), 299–218.
Buckley, N. E., Hansson, S., Harta, G., Mezey, E. (1998) Expression of the CB1 and CB2 receptor mRNAs during embryonic development in the rat. Neuroscience 82(4), 1131–1149.
Bouaboula, M., Rinaldi, M., Carayon, P., et al. (1993) Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214, 173–180.
Daaka, Y., Klein, T. W., and Friedman, H. (1995) Expression of cannabinoid receptor mRNA in murine and human leukocytes. Adv. Exp. Med. Biol,. 373,. 91–96.
Galiegue, S., et al. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232,. 54–61.
Schatz, A. R., Lee, M., Condie, R. B., Pulaski, J. T., Kaminski, N. E. (1997) Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol. Appl. Pharmacol. 142, 278–287.
Kaminski, N. E., Abood, M. E., Kessler, F. K., Martin, B. R., Schatz, A. R. (1992) Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol. Pharmacol. 42, 736–742.
McAllister, S. D. and Glass, M. (2002) CB1 and CB2 receptor-mediated signalling: a focus on endocannabinoids. Prostaglandins, Leukotrienes Essential Fatty Acids, 66(2&3), 161–171.
Howlett, A. C., Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., Porrino, L. J. (2004) Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47,. 345–358.
Bouaboula, M., Poinot-Chazel, C., Marchand, J. et al. (1996) Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur J. Biochem.. 237, 704.
Ellert-Miklaszewska, A., Kaminska, B., and. Konarska, L. (2005) Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein. Cell Signal 17(1), 25–37.
Karanian, D. A., Brown, Q. B., Makriyanis, A., Bahr, B. A. (2005) Blocking cannabinoid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampus. Eur. J. Pharmacol,. 508(1–3), 47–56.
Powles, T., te Poele, R., Shamash, J., et al. (2005) Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway. Blood 105(3), 1214–1221.
Buckley, N. E., McCoy, K. L., Mezey, E., et al. (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor. Eur. J. Pharmacol. 396, 141–149.
Chuchawankul, S., Shima, M., Buckley, N. E., Hartmann, C. B., McCoy, K. L. (2004) Role of cannabinoid receptors in inhibiting macrophage costimulatory activity. Int. Immunopharmacol. 4(2), 265–278.
Rinaldi-Carmona, M., Barth F., Millan, J., et al. (1998) SR 144528, the first and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther 284(2), 644–650.
Carayon, P., Marchand, J., Dussossoy, D., et al. (1998) Modulation and functional involvemnet of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood 92(10), 3605–3615.
Bouaboula, M., Desnoyer, N., Carayon, P., Combes, T., Casellas, P. (1999) Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation. Mol. Pharmacol. 55, 473–480.
Bouaboula, M.,. Dussossoy, D., and Casellas, P. (1999) Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. implications for receptor biological responses. J. Biol. Chem. 274(29), 20397–20405.
Portier, M., Rinaldi-Carmona, M., Pecceu, F., et al. (1999) SR144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist. J. Pharmacol. Exp. Ther. 288(2), 582–589.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Buckley, N.E., Burbridge, D., Buranapramest, M., Ferguson, T., Paau, R.Y. (2006). Experimental Methods to Study the Role of the Peripheral Cannabinoid Receptor in Immune Function. In: Onaivi, E.S. (eds) Marijuana and Cannabinoid Research. Methods In Molecular Medicine™, vol 123. Humana Press. https://doi.org/10.1385/1-59259-999-0:19
Download citation
DOI: https://doi.org/10.1385/1-59259-999-0:19
Publisher Name: Humana Press
Print ISBN: 978-1-58829-350-3
Online ISBN: 978-1-59259-999-8
eBook Packages: Springer Protocols